ADIAL PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2023.
  • Adial Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $18K, a 2.34% increase year-over-year.
  • Adial Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $70.2K, a 3.67% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $18K +$412 +2.34% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q1 2022 $17.6K +$7.22K +69.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $10.4K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $10.4K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.